← Back to Screener
Waters Corp (WAT)
Price$335.61
Favorite Metrics
Price vs S&P 500 (26W)-9.72%
Price vs S&P 500 (4W)0.13%
Market Capitalization$32.22B
P/E Ratio (Annual)50.14x
All Metrics
P/CF (Annual)49.38x
Book Value / Share (Quarterly)$43.01
P/TBV (Annual)11.29x
Revenue Growth (3Y)2.12%
Cash Flow / Share (Quarterly)$9.06
Price vs S&P 500 (YTD)-17.84%
Gross Margin (TTM)59.28%
Net Profit Margin (TTM)20.30%
EPS (TTM)$10.76
10-Day Avg Trading Volume0.77M
EPS Excl Extra (TTM)$10.76
Revenue Growth (5Y)6.00%
EPS (Annual)$10.76
ROI (Annual)16.19%
Gross Margin (Annual)59.22%
Net Profit Margin (5Y Avg)22.45%
Cash / Share (Quarterly)$9.87
P/E Basic Excl Extra (TTM)50.14x
Revenue Growth QoQ (YoY)6.83%
EPS Growth (5Y)5.19%
P/E Normalized (Annual)50.14x
ROA (Last FY)12.66%
Revenue Growth TTM (YoY)6.99%
EBITD / Share (TTM)$14.29
ROE (5Y Avg)88.92%
Operating Margin (TTM)25.36%
Cash Flow / Share (Annual)$9.06
P/B Ratio12.58x
P/B Ratio (Quarterly)8.83x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)10.44x
Net Interest Coverage (TTM)16.45x
ROA (TTM)13.35%
EPS Growth QoQ (YoY)-2.77%
EV / EBITDA (TTM)38.72x
EPS Incl Extra (Annual)$10.76
Current Ratio (Annual)1.73x
Quick Ratio (Quarterly)1.27x
3-Month Avg Trading Volume0.95M
52-Week Price Return2.08%
EV / Free Cash Flow (Annual)61.21x
P/E Incl Extra (TTM)50.14x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$33.64
P/S Ratio (Annual)10.18x
Asset Turnover (Annual)0.62x
52-Week High$414.15
Operating Margin (5Y Avg)27.97%
EPS Excl Extra (Annual)$10.76
CapEx CAGR (5Y)-8.14%
Tangible BV CAGR (5Y)8.69%
26-Week Price Return-0.98%
Quick Ratio (Annual)1.27x
13-Week Price Return-16.64%
Total Debt / Equity (Annual)0.55x
Current Ratio (Quarterly)1.73x
Enterprise Value$33,043.624
Revenue / Share Growth (5Y)6.94%
Asset Turnover (TTM)0.66x
Book Value / Share Growth (5Y)63.11%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.46x
Pretax Margin (Annual)23.85%
Cash / Share (Annual)$9.87
3-Month Return Std Dev39.51%
Gross Margin (5Y Avg)58.99%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)5.31%
EBITDA Interim CAGR (5Y)1.32%
ROE (Last FY)25.09%
Net Interest Coverage (Annual)15.87x
EPS Basic Excl Extra (Annual)$10.76
P/FCF (TTM)59.70x
Receivables Turnover (TTM)4.05x
EV / Free Cash Flow (TTM)61.21x
Total Debt / Equity (Quarterly)0.55x
EPS Incl Extra (TTM)$10.76
Receivables Turnover (Annual)4.05x
ROI (TTM)17.44%
P/S Ratio (TTM)10.18x
Pretax Margin (5Y Avg)26.28%
Revenue / Share (Annual)$53.01
Tangible BV / Share (Annual)$33.64
Forward P/E23.19x
Free OCF CAGR (5Y)-2.67%
Price vs S&P 500 (52W)-33.02%
P/E Ratio (TTM)50.14x
EPS Growth TTM (YoY)0.51%
Year-to-Date Return-13.71%
5-Day Price Return0.95%
EPS Normalized (Annual)$10.76
ROA (5Y Avg)16.90%
Net Profit Margin (Annual)20.30%
Month-to-Date Return10.06%
Cash Flow / Share (TTM)$13.53
EBITD / Share (Annual)$14.26
EPS Growth (3Y)-2.83%
Operating Margin (Annual)25.36%
LT Debt / Equity (Annual)0.37x
P/CF (TTM)49.38x
ROI (5Y Avg)24.77%
P/E Excl Extra (TTM)50.14x
LT Debt / Equity (Quarterly)0.37x
EPS Basic Excl Extra (TTM)$10.76
P/TBV (Quarterly)11.29x
P/B Ratio (Annual)8.83x
Inventory Turnover (TTM)2.46x
Pretax Margin (TTM)23.85%
Book Value / Share (Annual)$43.01
Price vs S&P 500 (13W)-19.51%
Net Margin Growth (5Y)-1.64%
Beta1.21x
P/FCF (Annual)59.70x
Revenue / Share (TTM)$52.88
ROE (TTM)28.52%
52-Week Low$275.05
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.73
3.84
3.86
3.86
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
WATWaters Corp | 10.18x | 6.00% | 59.28% | 25.36% | $335.61 |
AAgilent Technologies Inc. | 4.83x | 5.41% | 52.60% | 20.40% | $120.96 |
MTDMettler-Toledo International | 6.66x | 5.47% | 59.37% | 26.05% | $1324.66 |
ILMNIllumina Inc | 4.69x | 6.04% | 66.61% | 18.44% | $132.86 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $93.03 |
BIOBio-Rad Laboratories, Inc.Class A | 3.17x | 0.29% | 52.01% | 1.59% | $303.34 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.17x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRBruker Corporation | 1.81x | 11.57% | 47.13% | 1.40% | $41.10 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.81x | 11.57% | 47.13% | 1.40% | $320.13 |
AVTRAvantor, Inc. | 0.88x | 0.49% | 32.65% | -3.83% | $8.50 |
TXG10x Genomics, Inc. Class A Common Stock | 5.18x | 16.56% | 69.13% | -9.49% | $24.59 |
About
Waters manufactures analytical instruments including liquid chromatography, mass spectrometry, and thermal analysis systems. The company served biopharmaceutical (58%), industrial (31%), and academic/government (11%) customers in 2024. Waters has announced a merger with BD's life science and diagnostics business expected in early 2026, which will add diagnostics capabilities and expand its life sciences product portfolio.